about
Beyond Monoamines-Novel Targets for Treatment-Resistant Depression: A Comprehensive ReviewThe relationship of endogenous cortisol to psychiatric disorder: a reviewThe role of Akt/FoxO3a in the protective effect of venlafaxine against corticosterone-induced cell death in PC12 cellsRegulation of corticosteroid receptor gene expression in depression and antidepressant actionEffects of adrenal cortex hormones on limbic structures: some experimental and clinical correlations related to depression.Possible use of glucocorticoid receptor antagonists in the treatment of major depression: preliminary results using RU 486Treatment with staphylococcus toxoid in fibromyalgia/chronic fatigue syndrome--a randomised controlled trial.The Hypothalamic-Pituitary-Adrenal Axis in Major Depressive Disorder: A Brief Primer for Primary Care PhysiciansAntidepressants, but not antipsychotics, modulate GR function in human whole blood: an insight into molecular mechanisms.Antidepressants reverse corticosterone-mediated decrease in brain-derived neurotrophic factor expression: differential regulation of specific exons by antidepressants and corticosterone.Stress hormone-related psychopathology: pathophysiological and treatment implications.Implication of the hypothalamic-pituitary-adrenal axis in the physiopathology of depressionHypothalamic Proteomic Analysis Reveals Dysregulation of Glutamate Balance and Energy Metabolism in a Mouse Model of Chronic Mild Stress-Induced Depression.Clomipramine in vitro reduces glucocorticoid receptor function in healthy subjects but not in patients with major depression.Depressive symptoms, bone loss, and fractures in postmenopausal women.Prenatal alcohol exposure and chronic mild stress differentially alter depressive- and anxiety-like behaviors in male and female offspring.Serotonin modulates the suppressive effects of corticosterone on proliferating progenitor cells in the dentate gyrus of the hippocampus in the adult ratReduced thalamic volumes in major depressive disorder.Progesterone modulation of alpha5 nAChR subunits influences anxiety-related behavior during estrus cycle.In vitro modulation of the glucocorticoid receptor by antidepressants.HPA axis in major depression: cortisol, clinical symptomatology and genetic variation predict cognition.Metabolomic Biomarkers in Urine of Cushing's Syndrome Patients.Cushing’s disease and melancholia.Are medical comorbid conditions of bipolar disorder due to immune dysfunction?BDNF in sleep, insomnia, and sleep deprivation.Dehydroepiandrosterone (DHEA)--the "mother steroid". I. Immunologic action.Psychobiological consequences of social relationships.Steroid effects on brain functions: an example of the action of glucocorticoids on central dopaminergic and neurotensinergic systems.Chronic antidepressant treatments decrease pro-opiomelanocortin mRNA expression in the pituitary gland: effects of acute stress and 5-HT(1A) receptor activation.Corticosterone modulation of somatodendritic 5-HT1A receptor function in mice.Double-blind antiglucocorticoid treatment in schizophrenia and schizoaffective disorder: a pilot study.Neurotransmitters, neurosteroids and neurotrophins: new models of the pathophysiology and treatment of depression.Glucocorticoid receptor antagonists: new tools to investigate disorders characterized by cortisol hypersecretion.Bipolar Disorder and Immune Dysfunction: Epidemiological Findings, Proposed Pathophysiology and Clinical Implications.Regulation of 5-HT receptors and the hypothalamic-pituitary-adrenal axis. Implications for the neurobiology of suicide.Variation of plasma cortisol levels in patients with depression after treatment with bilateral electroconvulsive therapy.Repeated administration of dexamethasone increases phosphoinositide-specific phospholipase C activity and mRNA and protein expression of the phospholipase C beta 1 isozyme in rat brain.Activation of nuclear factor kappaB by nitric oxide in rat striatal neurones: differential inhibition of the p50 and p65 subunits by dexamethasone.The enhanced expression of c-Jun immunoreactivity in the adrenalectomized gerbil hippocampus.Acute and long-term treatments with the selective serotonin reuptake inhibitor citalopram modulate the HPA axis activity at different levels in male rats.
P2860
Q26782993-83424657-AB29-45AE-88D6-FF2BCF1F1678Q28238876-56709A0F-5DDF-4765-98FE-12E2AC844DD3Q28570801-7E31813F-71EC-4DBC-8714-A05B3DCA47CBQ30498987-B799898D-9F34-4993-8145-14A0D9A727A2Q33921155-075282C2-F5CC-47DA-BA06-AB2231A27849Q33921299-8DA1AA39-FBF2-4EAD-B5A3-DFD0CAA5C94EQ34157411-7A907CCE-55F7-437E-B1F6-1FF08388C6A2Q34304937-07B14003-79FF-4116-88E5-8371453B4823Q34315494-90F9B6DA-E08A-4AED-9B72-E8E21B98D565Q34806426-7A504B8B-C589-453A-AE47-9C7E3B83B08EQ35066496-58C588C7-365A-48FA-893D-8D8CC1EEB483Q35790395-3B42E359-3D10-4B65-AA43-E0C9875DB0D9Q36031835-9720A80A-58FA-4493-8A20-642EA931272FQ36442038-D6A95B5E-21FB-4F26-98FA-51510E4E9326Q36572715-3DFAD32A-5E21-4AE9-9CB3-E503725B4172Q36803104-5ED4E4D9-3B24-4C95-85F5-2A7AE19C54E1Q37117216-89EA1BC3-7E35-4F50-80B5-7A06264F0B05Q37131344-B6AB18CC-2569-48F8-921C-8095E53A36FFQ37266098-45B6E5C7-F900-4C15-800B-AD41D318D4A7Q37344256-6B4C1BAC-AC97-4617-8CB7-06922B4186E3Q37647371-7416E41E-D4C6-47AB-BAC4-99E0D1759250Q37690743-0270C232-F06D-41DC-90D9-8776D731060DQ37995205-4F649FD1-4F2D-47CE-A131-AF33BFD5DEF0Q38378743-56DBE441-0DC5-40EC-B1E4-7ABAAC95B990Q38693724-542DCE49-E662-41B7-8A64-E6DBF8695605Q40660578-B72058F7-F651-4E39-9C4E-C6465E072961Q41385175-E61330B7-3928-47A9-A8CC-A689F62F9714Q42939729-F19F78B2-2D63-4617-86BB-EA80061C23AEQ43778529-ABF4B07B-0946-4BB8-A085-5431DBAB6994Q44140174-7DA18E2C-97A6-47F6-893C-8A331BBE3B63Q44246724-536DD644-1EE0-4583-B406-421729DC66D9Q44519524-F7257384-6430-4522-8934-E12DF59786EAQ46600730-01F14914-9BD9-492E-A18D-5F62796D6576Q47667767-E2B8250D-36AA-49FA-BFBA-208F30D3F0E7Q48003250-806B7821-E064-479C-A7CA-5E4A7850A760Q48085955-FAAAE202-9A60-457B-AF22-97A87D5A1950Q48148928-F743028D-8C72-4E92-BD4B-278A70E2D629Q48174963-E09887F0-774F-46D9-A7B0-E28C639910C7Q48200694-EA40C3BB-FA2B-450F-85E3-300179A195F4Q48204775-514C7C75-CDE1-4775-B0BC-061DD03D181D
P2860
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年学术文章
@wuu
1991年学术文章
@zh-cn
1991年学术文章
@zh-hans
1991年学术文章
@zh-my
1991年学术文章
@zh-sg
1991年學術文章
@yue
1991年學術文章
@zh
1991年學術文章
@zh-hant
name
Steroids and depression.
@ast
Steroids and depression.
@en
type
label
Steroids and depression.
@ast
Steroids and depression.
@en
prefLabel
Steroids and depression.
@ast
Steroids and depression.
@en
P1476
Steroids and depression.
@en
P2093
P304
P356
10.1016/0960-0760(91)90312-S
P577
1991-05-01T00:00:00Z